Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Antibodies targeting modified citrullinated vimentin in patients with psoriatic arthritis (CROSBI ID 553323)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Tešija-Kuna, Andrea ; Miler, Marijana ; Grazio, Simeon ; Grubišić, Frane ; Vukasović, Ines ; Perić, Porin Antibodies targeting modified citrullinated vimentin in patients with psoriatic arthritis // Clinical chemistry and laboratory medicine. Special supplement / Siest, Gerard (ur.). 2009. str. S117-S117

Podaci o odgovornosti

Tešija-Kuna, Andrea ; Miler, Marijana ; Grazio, Simeon ; Grubišić, Frane ; Vukasović, Ines ; Perić, Porin

engleski

Antibodies targeting modified citrullinated vimentin in patients with psoriatic arthritis

Background: Recently it has been found that antibodies against modified citrullinated vimentin (anti-MCV) have comparable performance in diagnosis of rheumatoid arthritis (RA) as the antibodies targeting citrullinated peptides (anti- CCP). While anti-CCP is present in up to 15% of psoriatic arthritis (PsA) patients, the prevalence of anti-MCV in PsA patients has been poorly investigated. Our objective was to determine the prevalence and significance of anti MCV antibodies in patients with PsA. Methods: The study included 56 patients with PsA (29 male, 27 female, mean age 57± ; 12 years). Clinical features, disease activity and functional ability were noted by experienced rheumatologist. Serum samples of all patients were analyzed for anti-MCV antibodies using commercially available ELISA (Orgentec Diagnostika). Anti-CCP antibodies with ELISA (Euroimmun) and RF with latex immunoturbidimetry were also determined in all patients. Results: Anti-MCV antibodies were positive in 2/56 (3.6%) PsA patients. In one patient anti-MCV level was medium/high while in other borderline. Both patients had asymmetric polyarthritis, dactylitis and were anti-CCP and RF negative. five clinical types of PsA. No correlation between anti-MCV levels and disease activity variables or results of Health Assessment Questionnaire (HAQ) was found. Anti-CCP antibodies were negative in all patients. Conclusions: According to our findings the anti-MCV antibodies can be detected in a small proportion of PsA patients. Although the presence of anti-MCV in these patients with polyarthritic disease could presume psoriasis with concomitant RA, most of the clinical characteristics favor PsA as the primary diagnosis.

rheumatoid arthritis ; citrullinated vimentin ; psoriatic arthritis

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S117-S117.

2009.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Clinical chemistry and laboratory medicine. Special supplement

Siest, Gerard

Berlin: Walter de Gruyter

1437-8523

Podaci o skupu

18th IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine

poster

07.06.2009-11.06.2009

Innsbruck, Austrija

Povezanost rada

Farmacija, Kliničke medicinske znanosti

Poveznice